A. V. Gorbacheva

A. V. Gorbacheva

Auto-generated profile, based on publicly available information

A. V. Gorbacheva

Sechenov University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2026 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
KKK. A. Kammaev
K. A. Kammaev
TKT. V. Khorobrykh
T. V. Khorobrykh
DPD. D. Protsenko
D. D. Protsenko
APA. R. Patalova
A. R. Patalova
AGA. V. Gorbacheva
A. V. Gorbacheva
ЛШЛ. Р. Шакарова
Л. Р. Шакарова
Background. COVID-19-associated coagulopathy is a major manifestation of severe SARS-CoV-2 infection and is characterized by hypercoagulability, endothelial dysfunction, marked systemic inflammation, and microvascular dysfunction. Despite extensive research on hemostatic abnormalities in COVID-19, the role of COVID-19-associated coagulopathy in gastroduodenal ulcerative lesions complicated by gastrointestinal ulceration and gastrointestinal bleeding remains poorly understood. Objective: To characterize COVID-19-associated coagulopathy in patients with gastroduodenal bleeding and determine the relationships between laboratory hemostatic parameters, the severity of lung involvement, hypoxemia, and the endoscopic characteristics of gastroduodenal ulceration. Material and methods. This retrospective study included 72 patients with COVID-19 pneumonia complicated by gastroduodenal bleeding. The analysis included parameters of primary and secondary hemostasis, markers of systemic inflammation, the extent of lung involvement on computed tomography, oxygen saturation, and the morphological characteristics of the ulcers. Correlation and logistic regression analyses were performed to identify factors associated with in-hospital mortality. Results. Patients exhibited pronounced COVID-19-associated coagulopathy, with elevated D-dimer and fibrinogen concentrations, increased C-reactive protein levels, and abnormalities of primary hemostasis. The extent of lung involvement and oxygen saturation were significantly associated with the morphological characteristics of the ulcers. Conclusion. In patients with gastroduodenal bleeding, COVID-19-associated coagulopathy is characterized by both hypercoagulability and hypocoagulability in the setting of pronounced systemic inflammation. The extent of gastroduodenal ulceration is associated not only with laboratory manifestations of coagulopathy but also with the severity of lung involvement, hypoxemia, thrombocytopenia, and ulcer morphometry.